Switch Therapeutics Email Formats

Biotechnology Research • San Francisco, California, United States • 21-50 Employees

Switch Therapeutics Email Formats

Switch Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@switchthera.com), used 82.1% of the time.

Format	Example	Percentage
{first initial}	j@switchthera.com	82.1%
{first name}	john@switchthera.com	17.9%

Key Contacts at Switch Therapeutics

Dee Datta

Co-Founder And Ceo

Marina Kovaliov

Director Of Chemistry

Charles Allerson

Chief Technology Officer

Shilpi Mahajan

Director, Head Of Bioanalytics

Abhinav Kumar

Senior Director

Clara Tourino

Director

Company overview

Headquarters	San Francisco, California, United States
Phone number	+14155189678
Website	switchthera.com
NAICS	541714
Founded	2020
Employees	21-50
Socials

About Switch Therapeutics

Switch Therapeutics is an emerging preclinical stage biotechnology company pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science with the goal of treating a range of diseases – affecting the central nervous system and systemic indications – with significant unmet needs. Switch’s novel gene knockdown approach is based on technology developed by renowned researchers in the field of RNA from Caltech, Harvard and City of Hope. Based on the scientific discovery of Switch’s co-founders, the company has developed a novel proprietary platform known as CASi (Conditionally Activated siRNAs) that combines advantageous properties of both single and double-stranded RNAs in a single molecule, allowing for cell selective RNAi activity. To date, Switch has raised $52M in funding through Series A, and the company’s South San Francisco based team has continued to grow as its research has advanced.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Senior

Entry

Vice President

Employees by Department

Switch Therapeutics has 13 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Switch Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-04-14	4	$52,000,000

Funding Insights

$52,000,000

Total funding amount

$52,000,000

Most recent funding amount

Number of funding rounds

Switch Therapeutics Tech Stack

Discover the technologies and tools that power Switch Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Astra

WordPress themes

mOxie

JavaScript libraries

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

Elementor Header & Footer Builder

WordPress plugins

Tailwind CSS

UI frameworks

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Google Maps

Maps

Module Federation

Miscellaneous

Frequently asked questions

Switch Therapeutics is located in San Francisco, California, US.

You can reach Switch Therapeutics at +14155189678.

Switch Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Switch Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Switch Therapeutics has raised a total of $52,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Switch Therapeutics

Dee Datta

Co-Founder And Ceo

Marina Kovaliov

Director Of Chemistry

Charles Allerson

Chief Technology Officer

Shilpi Mahajan

Director, Head Of Bioanalytics

Abhinav Kumar

Senior Director

Clara Tourino